Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Net Cash Flow (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Net Cash Flow data on record, last reported at $43.1 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 205.13% year-over-year to $43.1 million; the TTM value through Dec 2025 reached $36.3 million, changed N/A, while the annual FY2025 figure was $731.9 million, 9020.05% up from the prior year.
  • Net Cash Flow reached $43.1 million in Q4 2025 per CAI's latest filing, up from $34.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $43.1 million in Q4 2025 and bottomed at -$71.2 million in Q3 2024.